These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3879960)

  • 1. Studies on the mechanism of action of an antibody-targetted drug-carrier conjugate.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Anticancer Drug Des; 1985 Oct; 1(1):3-12. PubMed ID: 3879960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
    Garnett MC; Baldwin RW
    Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
    Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of action of an MTX-HSA-MoAb conjugate.
    Fitzpatrick JJ; Garnett MC
    Anticancer Drug Des; 1995 Jan; 10(1):11-24. PubMed ID: 7695811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
    Shen WC; Ballou B; Ryser HJ; Hakala TR
    Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
    Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
    NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
    Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW
    Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
    Yin Z
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxicity of the conjugate adriamycin with anti-sarcoma monoclonal antibody 19-24.
    Mohamed G; Kuzmanoff KM; Stastny JJ; Das Gupta TK
    Anticancer Res; 1992; 12(2):529-32. PubMed ID: 1580569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.
    Colombatti M; Dell'Arciprete L; Chignola R; Tridente G
    Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Int J Cancer; 1983 May; 31(5):661-70. PubMed ID: 6852982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
    Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
    Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
    Seon BK
    Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular delivery of methotrexate by a receptor-mediated process.
    Mukhopadhyay A; Basu SK
    Biotechnol Appl Biochem; 1990 Oct; 12(5):529-36. PubMed ID: 2288708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.